Background: We propose a novel prognostic biomarker-based strategy for increasing the
efficacy of radiotherapy (RT) in head and neck squamous cell carcinoma (HNSCC) …

Background Radiotherapy is an indispensable treatment modality in head and neck cancer
(HNC), while radioresistance is the major cause of treatment failure. The aim of this study is …

Background The advantages of radiotherapy for head and neck squamous cell carcinoma
(HNSCC) depend on the radiation sensitivity of the patient. Here, we established and …

Radiotherapy is the main treatment for nasopharyngeal carcinoma (NPC); however,
radioresistance limits the therapeutic efficacy and prognosis of patients with NPC. Here, we …

J Oral Pathol Med (2011) 40: 739–746 Background: Radiotherapy is the main therapy for
head and neck squamous cell carcinoma (HNSCC); however, treatment resistance and local …

Aim: The aim of our study was to investigate the potential predictive value of the combination
of radiosensitivity gene signature and PD-L1 expression for the prognosis of locally …

Purpose The aim of the study is to identify a reliable gene panel to predict the prognosis of
HNSCC patients by integrated genomic analysis. Methods Co-expression gene networks …

Head and neck squamous cell carcinoma (HNSCC) is a malignant tumor. Radiotherapy (RT)
is an important treatment for HNSCC, but not all patients derive survival benefit from RT due …

Purpose Global gene expression analysis was performed on pre-treatment biopsies from
patients with squamous cell carcinoma of the head and neck (SCCHN) to discover …

Radiotherapy remains the backbone of head and neck cancer therapy but response is
sometimes impeded by tumor radioresistance. Identifying predictive biomarkers of …